Wakefield Asset Management Lllp Haemonetics Corp Transaction History

Wakefield Asset Management Lllp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 28, 2020	SELL	$84.96 - $118.91 $395,318 - $553,288	-4,653 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$74.34 - $121.82 $44,009 - $72,117	592 Added 14.58%	4,653 $464,000
Q4 2019 Jan 27, 2020	SELL	$114.37 - $129.46 $6,976 - $7,897	-61 Reduced 1.48%	4,061 $467,000
Q3 2019 Oct 25, 2019	SELL	$117.16 - $138.52 $101,812 - $120,373	-869 Reduced 17.41%	4,122 $520,000
Q2 2019 Aug 13, 2019	BUY	$81.74 - $120.34 $407,964 - $600,616	4,991 New	4,991 $601,000

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.39B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Wakefield Asset Management Lllp with notifications on news.